Medical Condition News

RSS

Novartis files marketing authorisation with EMA for NVA237 to treat COPD

Sosei Group Corporation, today announces that NVA237 (glycopyrronium bromide), a long-acting muscarinic antagonist (LAMA) being investigated as a once-daily treatment for chronic obstructive pulmonary disease (COPD), has been filed by Novartis for marketing authorisation with the European Medicines Agency (EMA), under the brand-name Seebri Breezhaler, triggering a $5m milestone payment to Sosei.

27 Sep 2011

Photocure, Ipsen partner to commercialise Hexvix for diagnosis of bladder cancer

Ipsen announces today a partnership with Photocure, a specialty pharmaceutical company focused on photodynamic technologies in cancer and dermatology.

27 Sep 2011

High consumption of caffeinated coffee appears to reduce risk of depression in women

The risk of depression appears to decrease for women with increasing consumption of caffeinated coffee, according to a report in the September 26 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

27 Sep 2011

Statistical algorithm can now determine focus error in eyes, cameras

University of Texas at Austin researchers have discovered how to extract and use information in an individual image to determine how far objects are from the focus distance, a feat only accomplished by human and animal visual systems until now.

27 Sep 2011

UNC CDTR aims to reduce diabetes-related health disparities

The University of North Carolina at Chapel Hill has received a $3 million, 5-year grant from the National Institute of Diabetes and Digestive and Kidney Diseases to establish the UNC Center for Diabetes Translation Research to Reduce Health Disparities.

27 Sep 2011

University of Zurich receives AICR grant to improve vaccines against Burkitt's lymphoma

Research in Switzerland could help reduce the time taken to develop vaccines against cancer tumours.

27 Sep 2011

Eating blueberries may inhibit breast cancer tumor growth

Eating blueberries may inhibit breast cancer tumor growth, according to a recent study by researchers at the City of Hope in Los Angeles that is published in the October 2011 issue of The Journal Of Nutrition and featured in the September issue of Food Nutrition & Science.

27 Sep 2011

Data from YM BioSciences' nimotuzumab clinical trials to be reported at ECCO-ESMO 2011

YM BioSciences Inc., a drug development company advancing a diverse portfolio of hematology and cancer-related products, today announced that data from several clinical trials of nimotuzumab are scheduled be reported at the 2011 European Multidisciplinary Cancer Congress (ECCO-ESMO), September 23-27, 2011, in Stockholm, Sweden.

27 Sep 2011

Endologix develops Ventana stent graft system to treat aortic aneurysms

The Methodist Hospital has been chosen as a study site for a new type of stent graft device that is designed for the repair of certain types of aortic aneurysms near or involving the blood vessels that lead to the kidneys. The Ventana Fenestrated Stent Graft System is made by Endologix Inc., which is sponsoring both the feasibility and pivotal studies of the device.

27 Sep 2011

Research roundup: Widows and medical spending; disparities in heart care, hospital deaths

The authors write: "We find that out-of-pocket medical spending is approximately 29 percent higher when an individual becomes widowed, a large portion of which is spending on nursing homes. Our results suggest a substantial role of living arrangements in out-of-pocket medical spending; however, our estimates combined with differences in rates of widowhood across gender suggest that marital status can explain only one third of the gender difference in total out-of-pocket medical spending, leaving a large portion unexplained.

27 Sep 2011

Vitamin B12 deficiency linked to cognitive problems or loss in brain volume among older people

Older people with low levels of vitamin B12 in their blood may be more likely to lose brain cells and develop problems with their thinking skills, according to a study published in the September 27, 2011, print issue of Neurology, the medical journal of the American Academy of Neurology.

27 Sep 2011

Physical activity improves arthritis symptoms in obese mice

Adding another incentive to exercise, scientists at Duke University Medical Center have found that physical activity improves arthritis symptoms even among obese mice that continue to chow down on a high-fat diet.

27 Sep 2011

Study: Underweight COPD patients more likely to face death

Patients suffering from chronic obstructive pulmonary disease (COPD) are at a higher risk of death if they are underweight.

27 Sep 2011

UCSF, QuantiaMD develop new DiabetesIQ mobile phone app

A new interactive mobile phone app called DiabetesIQ, released this week, challenges people to test their knowledge of diabetes and to compete with one another as they learn about the complexities of the disease, which affects more than 25 million Americans, including 4 million Californians.

27 Sep 2011

Synta announces results of ganetespib, docetaxel Phase 1 combination study on solid tumors

Synta Pharmaceuticals Corp. announced that results of a Phase 1 study of ganetespib in combination with docetaxel in solid tumors were presented at the Annual Meeting of the European Society of Medical Oncology in Stockholm, Sweden.

27 Sep 2011

Communication breakdown between nerves and muscles in SMA mouse model

Researchers at the University of Missouri have identified a communication breakdown between nerves and muscles in mice that may provide new insight into the debilitating and fatal human disease known as spinal muscular atrophy.

27 Sep 2011

Viewing computer images causes long-term changes in nerve cell connections

Viewing two-dimensional images of the environment, as they occur in computer games, leads to sustained changes in the strength of nerve cell connections in the brain.

27 Sep 2011

Alnylam commences ALN-PCS Phase I trial in severe hypercholesterolemia

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has initiated dosing in its Phase I clinical trial with ALN-PCS, an RNAi therapeutic targeting proprotein convertase subtilisin/kexin type 9, or PCSK9, for the treatment of severe hypercholesterolemia.

27 Sep 2011

Collegium completes Type A meeting with FDA for COL-003 Phase III chronic low back pain study

Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, announced today that it has successfully completed a Type A meeting with the U.S. Food and Drug Administration (FDA) regarding the proposed Phase III clinical study for COL-003, the Company's tamper-resistant, extended release oxycodone product utilizing its proprietary DETERx technology.

27 Sep 2011

Smaller and faster clinical drug trials could improve gains in cancer survival

With the advent of personalised medicine, gains in cancer survival over the long term could be improved by running smaller, faster trials with less stringent evidence criteria, a researcher told the 2011 European Multidisciplinary Cancer Congress.

26 Sep 2011

Medical Condition News

Novartis files marketing authorisation with EMA for NVA237 to treat COPD

Photocure, Ipsen partner to commercialise Hexvix for diagnosis of bladder cancer

High consumption of caffeinated coffee appears to reduce risk of depression in women

Statistical algorithm can now determine focus error in eyes, cameras

UNC CDTR aims to reduce diabetes-related health disparities

University of Zurich receives AICR grant to improve vaccines against Burkitt's lymphoma

Eating blueberries may inhibit breast cancer tumor growth

Data from YM BioSciences' nimotuzumab clinical trials to be reported at ECCO-ESMO 2011

Endologix develops Ventana stent graft system to treat aortic aneurysms

Research roundup: Widows and medical spending; disparities in heart care, hospital deaths

Vitamin B12 deficiency linked to cognitive problems or loss in brain volume among older people

Physical activity improves arthritis symptoms in obese mice

Study: Underweight COPD patients more likely to face death

UCSF, QuantiaMD develop new DiabetesIQ mobile phone app

Synta announces results of ganetespib, docetaxel Phase 1 combination study on solid tumors

Communication breakdown between nerves and muscles in SMA mouse model

Viewing computer images causes long-term changes in nerve cell connections

Alnylam commences ALN-PCS Phase I trial in severe hypercholesterolemia

Collegium completes Type A meeting with FDA for COL-003 Phase III chronic low back pain study

Smaller and faster clinical drug trials could improve gains in cancer survival

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News